author-photo

Susan Wee

Bristol-Myers Squibb

16

Papers

835

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

DGKζ exerts greater control than DGKα over CD8+ T cell activity and tumor inhibition

2021 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract A68: A casein kinase 2 inhibitor disorders myeloid cell differentiation by blocking CCAAT/enhancer-binding protein-alpha signaling pathway in tumor microenvironment

2020
Show All
- Source
- Cite
- Save
Citations (0)
Discovery of Pyridazinone and Pyrazolo[1,5-a]pyridine Inhibitors of C-terminal Src Kinase

2019 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (6)
Abstract B198: Targeting CSK kinase activity to enhance antitumor immunity

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 5789: Discovery of clinical candidate BMS-986158, an oral BET inhibitor, for the treatment of cancer

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (10)
Inhibition of Casein Kinase 2 Disrupts Differentiation of Myeloid Cells in Cancer and Enhances the Efficacy of Immunotherapy in Mice

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (20)
Systemic Loss of C-terminal Src Kinase Expression Elicits Spontaneous Suppurative Inflammation in Conditional Knockout Mice

2018 Veterinary Pathology
Show All
- Source
- Cite
- Save
Citations (5)
411OInitial results from a phase I/IIa trial evaluating BMS-986158, an inhibitor of the bromodomain and extra-terminal (BET) proteins, in patients (pts) with advanced cancer

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (11)
Abstract B02: Targeting CSK kinase activity to enhance antitumor immunity

2018 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 5792: Preclinical antitumor activity of BMS-986158, an oral BET inhibitor, for the treatment of cancer

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)